Early-stage, HER2-positive Breast Cancer Patients At Increased Risk Of Recurrence

Early-stage breast cancer patients with HER2 positive tumors one centimeter or smaller are at significant risk of recurrence of their disease, compared to those with early-stage disease who do not express the aggressive protein, according to a new study.

Read the whole article on Science Daily

More from Science Daily